References

Beck, S., & Koster, H. (1990). Applications of dioxetane chemiluminescent probes to molecular biology. Anal Chem, 62, 2258-2270.

Beld, M., Sentjens, R., Rebers, S., Weegink, C., Weel, J., Sol, C., & Boom, R. (2002). Performance of the new Bayer VERSANT HCV RNA 3.0 assay for quantitation of hepatitis C virus RNA in plasma and serum: conversion to international units and comparison with the Roche COBAS Amplicor HCV Monitor, version 2.0 assay. J Clin Microbiol, 40, 788-793.

Cao, Y., Ho, D.D., Todd, J. Kokka, R., Urdea, M., Ufson, J.D., Piatak, M., Chen, S., Hahn, B.H., Saag, M.S., et al. (1995). Clinical evaluation of branched DNA signal amplification for quantifying HIV type 1 in human plasma. AIDS Res Hum Retroviruses, 11, 353-361.

Castle, P. E., Schiffman, M., Burk, R.D., Hildesheim, A., Herrero, R., Bratti, M.C., Sherman, M.E., Schussler, J.E., & Lorincz, A.T. (2002). Restricted cross-reactivity of hybrid capture 2 Test with low-risk human papillomavirus types. Cancer Epidemiol Biomark Prev, 11, 1394-1399.

Castle, P.E., Lorincz, A.T., Scott, D.R., Sherman, M.E., Glass, A.G., Rush, B.B., Wacholder, S., Burk, R.D., Manos, M.M., Schussler, J.E., Macomber, P., & Schiffman, M. (2003). Comparison between prototype hybrid capture 3 and hybrid capture 2 human papillomavirus DNA assays for detection of high-grade cervical intraepithelial neoplasia and cancer. J Clin Microbiol, 41, 4022-4030.

Castle, P.E., Garcia-Meijide, M., Holladay, E.B., Chuke, R., Payne, J., Long, A., Siefers, H., Demuth, F., & Lorincz, A. T. (2005). A novel filtration-based processing method of liquid cytology specimens for human papillomavirus DNA testing by hybrid capture II. Am J Clin Pathol, 123, 250-255.

Clavel, C., Masure, M., Putaud, I., Thomas, K., Bory, J.P., Gabriel, R., Quereux, C., & Birembaut, P. (1998). Hybrid capture II, a new sensitive test for human papillomavirus detection. Comparison with hybrid capture I and PCR results in cervical lesions. J Clin Pathol, 51, 737-740.

Clavel, C., Masure, M., Bory, J.P., Putaud, I., Mangeonjean, C., Lorenzato, M., Gabriel, R., Quereux, C., & Birembaut, P. (1999). Hybrid capture Il-based human papillomavirus detection, a sensitive test to detect routine high-grade cervical lesions: a preliminary study on 1518 women. Br J Cancer, 80, 1306-1311.

Collins, M.L., Zayati, C., Detmer, J.J., Daly, B., Kolberg, J.A., Cha, T.A., Irvine, B.D., Tucker, J., & Urdea, M.S. (1995). Preparation and characterization of RNA standards for use in quantitative branched DNA hybridization assay. Anal. Biochem, 226, 120-129.

Collins, M.L., Irvine, B., Tyner, D., Fine, E., Zayati, C., Chang, C.A., Horn, T., Ahle, D., Detmer, J., Shen, L.P., Kolberg, J., Bushnell, S., Urdea, M.S., & Ho, D.D. (1997). A branched DNA signal amplification assay for quantification of nucleic acid targets below 100 molecules/ml. Nucleic Acids Res, 25, 2979-2984.

Cullen, A.P., Long, C.D., & Lorincz, A.T. (1997). Rapid detection and typing of herpes simplex virus DNA in clinical specimens by the hybrid capture II signal amplification probe test. J Clin Microbiol, 35, 2275-2278.

Cuzick, J., Beverley, E., Ho, L., Terry, G., Sapper, H., Mielzynska, I., Lorincz, A., Chan, W-K., Krausz, T., & Soutter, P. (1999). HPV testing in primary screening of older women. Br J Cancer, 81, 554-558.

Cuzick, J. (2000). Human papillomavirus testing for primary cervical cancer screening. JAMA, 283, 108-109.

Cuzick, J., Szarewski, A., Cubie, H., Hulman, G., Kitchener, H., Luesley, D., McGoogan, E., Menon, U., Terry, G., Edwards, R., Brooks, C., Desai, M., Gie, C., Ho, L., Jacobs, I., Pickles, C., & Sasieni, P. (2003). Management of women who test positive for high-risk types of human papillomavirus: the HART Study. Lancet, 362, 1871-1876.

Darwin, L.H., Cullen, A.P., Arthur, P.M., Long, C.D., Smith, K.R., Girdner, J.L., Hook, E.W. 3rd, Quinn, T.C., & Lorincz, A.T. (2002). Comparison of Digene hybrid capture 2 and conventional culture for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in cervical specimens. J Clin Microbiol, 40, 641-644.

Elbeik, T., Chalebois, E., Nassos, P., Kahn, J., Hecht, F.M., Yajko, D., Ng, V., & Hadley, K. (2000). Quantitative and cost comparison of ultrasensitive human immunodeficiency virus type 1 RNA viral load assays: Bayer bDNA Quantiplex version 3.0 and 2.0 and Roche PCR Amplicor Monitor 1.5. J Clin Microbiol, 38, 1113-1120.

Elbeik, T., Alvord, W.G., Trichavaroj, R., de Souza, M., Dewar, R., Brown, A., Chernoff, D., Michael, N.L., Nassos, P., Hadley, K., & Ng, V.L. (2002). Comparative analysis of HIV-1 viral load on subtype quantification Bayer Versant HIV-1 RNA 3.0 versus Roche Amplicor HIV-1 Monitor version 1.5. J Acquir Immune Defic Syndr, 29, 330339.

Elbeik, T., Surtihadi, J., Detree, M., Gorlin, J., Holodniy, M., Jortani, S.A., Kuramoto, K., Ng, V., Valdes, R., Valsamakis, A., & Terrault, N.A. (2004). Multicenter evaluation of the performance characteristics of the Bayer VERSANT HCV RNA 3.0 Assay (bDNA). J Clin Microbiol, 42, 563-569.

Erice, A., Brambilla, D., Bremer, J. Jackson, J.B., Kokka, R., Yen-Lieberman, B., & Coombs, R.W. (2000). Performance characteristics of the Quantiplex HIV-1 RNA 3.0 assay for detection and quantitation of human immunodeficiency virus type 1 RNA in plasma. J Clin Microbiol, 38, 2837-2845.

Germer, J.J., Heimgartner, P.J., Ilstrup, D.M., Harmsen, W.S., Jenkins, G.D., & Patel, R. (2002). Comparative evaluation of the VERSANT HCV RNA 3.0, QUANTIPLEX HCV RNA 2.0, and COBAS AMPLICOR HCV MONITOR version 2.0 assays for quantification of hepatitis C virus RNA in serum. J Clin Microbiol, 40, 495-200.

Girdner, J.L., Cullen, A.P., Salama, T.G., He L., Lorincz, A., & Quinn, T.C. (1999). Evaluation of the Digene hybrid capture II CT-ID test for the detection of Chlamydia trachomatis in female endocervical specimens. J Clin Microbiol, 37, 1579-1581.

Hendricks, D.A., Stowe, B.J., Hoo, B.S., Kolberg, J., Irvine, B.D., Neuwald, P.D., Ur-dea, M.S., & Perrillo, R.P. (1995). Quantitation of HBV DNA in human serum using a branched DNA (bDNA) signal amplification assay. Am J Clin Pathol, 104, 537-546.

Horn, T., & Ureda, M.S. (1989). Forks and combs and DNA: the synthesis of branched oligodeoxyribonucleotides. Nucleic Acids Res, 17, 6959-6967.

Jacob, S., Baudy, D., Jones, E., Xu, L., Mason, A., Regenstein, F., & Perrillo, R.P. (1997). Comparison of quantitative HCV RNA assay in chronic hepatitis C. Am J Clin Pathol, 107, 362-367.

Kenny, D., Shen, L.P., & Kolberg, J.A. (2002). Detection of viral infection and gene expression in clinical tissue specimens using branched DNA (bDNA) in situ hybridization. J Histochem Cytochem, 50, 1219-1227.

Kern, D., Collins, M., Fultz, T., Detmer, J., Hamren, S., Peterkin, J.J., Sheridan, P., Urdea, M., White, R., Yeghiazarian, T., & Todd, J. (1996). An enhanced sensitivity branched DNA assay for quantification of human immunodeficiency virus type 1 RNA in plasma. J Clin Microbiol, 34, 3196-3202.

Konnick, E.Q., Erali, M., Ashwood, E.R., & Hillyard, D.R. (2002). Performance characteristics of the COBAS Amplicor Hepatitis C Virus (HCV) Monitor, version 2.0, international unit assay and the National Genetics Institute HCV superquant Assay. J Clin Microbiol, 40, 768-773.

Konnick, E.Q., Erali, M., Ashwood, E.R., & Hillyard, D.R. (2005). Evaluation of the COBAS amplicor HBV monitor assay and comparison with the ultrasensitive HBV hybrid capture 2 assay for quantification of hepatitis B virus DNA. J Clin Microbiol, 43, 596-603.

Kulmala, S.M., Syrjanen, S., Shabalova, I., Petrovichev, N., Kozachenko, V., Podistov, J., Ivanchenko, O., Zakharenko, S., Nerovjna, R., Kljukina, L., Branovskaja, M., Grunberga, V., Juschenko, A., Tosi, P., Santopietro, R., & Syrjanen, K. (2004). Human papillomavirus testing with the hybrid capture 2 assay and PCR as screening tools. J Clin Microbiol, 42, 2470-2475.

Li, F., Zhao, C., Zhang, W., Cui, S., Meng, J., Wu, J., & Zhang, D. Y. (2005). Use of ramification amplification assay for detection of Escherichia coli 0157:H7 and other E. coli shiga toxin-producing strains. J Clin Microbiol, 43, 6086-6090.

Lin, H.J., Pedneault, L., & Hollinger, F.B. (1998). Intra-assay performance characteristics of five assays for quantification of human immunodeficiency virus type 1 RNA in plasma. J Clin Microbiol, 36, 835-839.

Lorincz, A., & Anthony, J. (2001). Hybrid capture method of detection of human papillomavirus DNA in clinical specimens. Papillomavirus Rep, 12, 145-154.

Lowe, M., Spiro, A., Zhang, Y. Z., & Getts, R. (2004). Multiplexed, particle-based detection of DNA using flow cytometry with 3DNA dendrimers for signal amplification. Cytometry, 60, 135-44.

Manos, M.M., Kinney, W.K., Hurley, L.B., Sherman, M.E., Shieh-Ngai, J., & Kurman, R.J. (1999). Identifying women with cervical neoplasia using human papillomavirus DNA testing for equivocal Papanicolaou results. JAMA, 281, 1605-1610.

Mazzulli, T., Drew, L.W., Yen-Lieberman, B., Jekic-McMullen, D., Kohn, D.J., Isada, C., Moussa, G., Chua, R., & Walmsley. (1999). Multicenter comparison of the digene hybrid capture CMV DNA assay (version 2.0), the pp65 antigenemia assay, and cell culture for detection of cytomegalovirus viremia.. J Clin Microbiol, 37, 958963.

Munoz, N., Bosch, F.X., de Sanjose, S., Herrero, R., Castellsague, X., Shah, K.V., Snijders, P.J., Meijer, C.J., & the International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. (2003). Human papillomavirus and cancer: the epidemiological evidence. N Engl J Med, 348, 518-527.

Murphy, D.G., Cote, L., Fauvel, M., Rene, P., & Vincelette, J. (2000). Multicenter comparison of Roche COBAS Amplcor Monitor version 1.5, Organon Technika NucliSens QT with extractor, and Bayer Quantiplex version 3.0 for quantitation of human immunodeficiency virus type 1 RNA in plasma. J Clin Microbiol, 38, 4034-4041.

Nolte, F.S. (1998). Branched DNA signal amplification for direct quantitation of nucleic acid sequences in clinical specimens. Adv Clin Chem, 33, 201-235.

Pachl, C., Todd, J.A., & Kern, G. (1995). Rapid and precise quantification of HIV-1 RNA in plasma using a branched DNA (bDNA) signal amplification assay. J Acquir Immune Defic Syndr Hum Retrovirol, 8, 446-454.

Peyton, C.L., Schiffman, M., & Lorincz, A. T. (1998). Comparison of PCR- and hybrid capture-based human papillomavirus detection systems with multiple cervical specimen collection strategies. J Clin Microbiol, 36, 3248-3254.

Player, A.N., Shen, L.P., Kenny, D., Antao, V.P., & Kolberg, J.A. (2001). Single-copy gene detection using branched DNA (bDNA) in situ hybridization. J Histochem Cytochem, 49, 603-612.

Qian, X., & Lloyd, R.V. (2003). Recent developments in signal amplification methods for in situ hybridization. Diagn Mol Pathol, 12, 1-13.

Schachter, J., Hook, E.W. 3rd, McCormack, W.M., Quinn, T.C., Chernesky, M., Chong, S., Girdner, J.I., Dixon, P.B., DeMeo, L., Williams, E., Cullen, A., & Lorincz, A. (1999). Ability of the digene hybrid capture II test to identify Chlamydia trachomatis and Neisseria gonorrhoeae in cervical specimens. J Clin Microbiol, 37, 3668-3671.

Schiffman, M., Herrero, R., Hildesheim, A., Sherman, M.E., Bratti, M., Wacholder, S., Alfaro, M., Hutchinson, M., Morales, J., Greenberg, M.D., & Lorincz, A.T. (2000). HPV DNA testing in cervical cancer screening: results from women in a high-risk province of Costa Rica. JAMA, 283, 87-93.

Sherman, M.E., Lorincz, A.T., Scott, D.R., Wacholder, S., Castle, P.E., Glass, A.G., Mielzyn-ska, I., Rush, B.B., & Schiffman, M. (2003). Cytology and human papillomavirus testing to determine risk for cervical neoplasia: a ten-year cohort analysis of 20,810 women. J Natl Cancer Inst, 95, 46-52.

Solomon, D., Schiffman, M., & Tarone, R. & the ALTS Study Group. (2001). Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: enrollment results from arandomized trial. J Natl Cancer Inst, 93,293-299.

Switzer, C.Y., Moroney, S.E., & Benner, S.A. (1993). Enzymatic recognition of the base pair between isocytidine and isoguanosine. Biochemistry, 32, 10489-10496.

Veillon, P., Payan, C., Picchio, G., Maniez-Montreuil, M., Guntz, P., & Lunel, F. (2003). Comparative evaluation of the total hepatitis C virus core antigen, branched-DNA, and amplicor monitor assays in determining viremia for patients with chronic hepatitis C during interferon plus ribavirin combination therapy. J Clin Microbiol, 41, 3212-3220.

Walboomers, J.M.M., Jacobs, M.V., Manos, M.M., Bosch, F.X., Kummer, J.A., Shah, K.V., Snijders, P.J.F., Peto, J., Meijer, C.J.L., & Munoz, N. (1999). Human papillomavirus is a necessary cause of invasive cervical cencer world-wide. J Pathol, 189, 12-19.

Wilber, J.C. (1997). Branched DNA for quantification of viral load. Immunol Invest, 26, 9-13.

Wright Jr., T.C., Denny, L., Kuhn, L., Pollack, A., & Lorincz, A. (2000). HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer. JAMA, 283, 81-86.

Yao, J.D., Beld, M.G., Oon, L.L., Sherlock, C.H., Germer, J., Menting, S., Se Thoe, S.Y., Merrick, L., Ziermann, R., Surtihadi, J., & Hnatyszyn, H.J. (2004). Multicenter evaluation of the VERSANT Hepatitis B Virus DNA 3.0 assay. J Clin Microbiol, 42, 800-806.

Yuan, H.J., Yuen, M.F., Wong, D.K., Sum, S.S., & Lai, C.L. (2004). Clinical evaluation of the digene hybrid capture II test and the COBAS AMPLICOR monitor test for determination of hepatitis B virus DNA levels. J Clin Microbiol, 42, 3513-3517.

Detection and Characterization of Molecular Amplification Products: Agarose Gel Electrophoresis, Southern Blot Hybridization, Restriction Enzyme Digest Analysis, and Enzyme-Linked Immunoassay

Raymond P. Podzorski, Mike Loeffelholz, and Randall T. Hayden

Was this article helpful?

0 0
10 Ways To Fight Off Cancer

10 Ways To Fight Off Cancer

Learning About 10 Ways Fight Off Cancer Can Have Amazing Benefits For Your Life The Best Tips On How To Keep This Killer At Bay Discovering that you or a loved one has cancer can be utterly terrifying. All the same, once you comprehend the causes of cancer and learn how to reverse those causes, you or your loved one may have more than a fighting chance of beating out cancer.

Get My Free Ebook


Post a comment